Skip to main content
Clinical Trials/NCT02532270
NCT02532270
Unknown
Not Applicable

Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring During Spinal Anaesthesia for Cesarean Section:A Prospective,Randomized, Controlled Study

Fudan University1 site in 1 country100 target enrollmentSeptember 2015
ConditionsHypotension
Interventionsphenylephrine

Overview

Phase
Not Applicable
Intervention
phenylephrine
Conditions
Hypotension
Sponsor
Fudan University
Enrollment
100
Locations
1
Primary Endpoint
the maximum change of systolic blood pressure(SBP),assessed using continuous non-invasive arterial pressure device or intermittent oscillometric arterial pressure measurement
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine whether continuous non-invasive arterial pressure (CNAP) monitoring is beneficial to maintain maternal hemodynamic stability and improve the outcomes of maternal and fetal comparing with intermittent oscillometric non-invasive arterial pressure (NIAP)measurement during spinal anaesthesia for cesarean section .

Detailed Description

Peri-operative hypotension and fluctuation of arterial blood pressure (BP) during spinal anaesthesia are common. Hypotension causes maternal side-effects such as unconsciousness, dizziness, nausea, and vomiting. The potential fetal side-effects are caused by a reduction in the uterine blood flow with consequent reduced oxygen supply and acidosis reflected by impaired blood gas analyses and impaired Apgar scores. Because of the potential harm to the fetus and the dependency of fetal oxygenation on maternal arterial pressure (AP), it has been strongly recommended to closely monitor mother's arterial pressure and to treat hypotension immediately. Non-invasive arterial pressure (NIAP) measurement is a common method for monitoring in clinical. These hypotension episodes probably would be detected with delay by NIAP measurement on account of its discontinuous. A monitor for continuous non-invasive arterial pressure monitoring (CNAPTM Monitor 500, CNSystems Medizintechnik AG,Graz, Austria) using the volume-clamped method. It can monitor timely and provide beat-to-beat value of arterial pressure. The purpose of this study is to determine whether continuous non-invasive arterial pressure (CNAP) monitoring is beneficial to maintain maternal hemodynamic stability and improve the outcomes of maternal and fetal.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
June 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chao Han

Department of Anesthesiology, Department of Obstetrics and Gynecology Hospital, Fudan University

Fudan University

Eligibility Criteria

Inclusion Criteria

  • scheduled for elective caesarean section with spinal anaesthesia
  • pregnancy week above 36

Exclusion Criteria

  • age\<18 yr
  • cardiac arrhythmia
  • vascular pathologies of the upper limbs (recent vascular surgery, Raynaud's disease, vascular stenosis)
  • contraindication for spinal anaesthesia
  • emergency case

Arms & Interventions

Group C

Arterial pressure of the patients in Group C is measured by continuous non-invasive arterial pressure (CNAP).When systolic blood pressure decreased by over 20% of the basic value or systolic blood pressure lower than 100mmHg after spinal anaesthesia,phenylephrine was administered 50ug .If systolic blood pressure did not improve after 1 minute,phenylephrine was administered repeatedly until systolic blood pressure return to normal.

Intervention: phenylephrine

Group N

Arterial pressure of the patients in Group N is measured by intermittent oscillometric non-invasive arterial pressure (NIAP).When systolic blood pressure decreased by over 20% of the basic value or systolic blood pressure lower than 100mmHg after spinal anaesthesia,phenylephrine was administered 50ug .If systolic blood pressure did not improve after 1 minute,phenylephrine was administered repeatedly until systolic blood pressure return to normal.

Intervention: phenylephrine

Outcomes

Primary Outcomes

the maximum change of systolic blood pressure(SBP),assessed using continuous non-invasive arterial pressure device or intermittent oscillometric arterial pressure measurement

Time Frame: between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

(baseline SBP-minimum SBP)/baseline SBP

Secondary Outcomes

  • the incidence of nausea and vomiting on account of hypotension(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)
  • Detecting the occurrence of hypotension(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)
  • the incidence of dizziness on account of hypotension(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)
  • Neonatal outcome was assessed with Apgar scores(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)
  • umbilical cord blood gases analysis at birth(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)
  • the incidence of dyspnea on account of hypotension(between the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins)

Study Sites (1)

Loading locations...

Similar Trials